Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors
- PMID: 1995097
Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors
Abstract
An intravenous solution of 99% pure globulin (hyperimmune IgG, HIVIG) was obtained from pooled plasma of selected human immunodeficiency virus (HIV-1)-seropositive asymptomatic donors with greater than 400 CD4+/microliters cells per microliter and a high titer of antibody to HIV-1 p24 protein. HIVIG had high titers of antibody to p24, glycoprotein 41 (gp41), and gp120, group-specific neutralizing activity, and binding to the gp120 hypervariable loop region. It inhibited syncytia formation. At low concentration, it enhanced viral production of HIV-1 in infected peripheral blood monocytes but was inhibitory at higher concentration. HIVIG directed group-specific antibody-dependent cellular cytotoxicity against HIV-infected targets. For a period of 6 to 28 months, plasma donors kept stable antibody titers and had a 1.0% decrease in CD4+ cells per month. One gram per kilogram HIVIG injected in two juvenile chimpanzees was well tolerated and did not transmit HIV, as measured by negative cell culture, IgM immune response to HIV proteins, and polymerase chain reaction. The mean half-life of HIV-1 p24 antibody was 15 days. These preliminary data suggest that HIVIG is a safe product suitable for clinical trial in HIV-1-infected individuals.
Similar articles
-
Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12.J Virol. 1997 Oct;71(10):7198-206. doi: 10.1128/JVI.71.10.7198-7206.1997. J Virol. 1997. PMID: 9311792 Free PMC article.
-
Comparison of two different preparations of HIV immune globulin for efficiency of neutralization of HIV type 1 primary isolates.AIDS Res Hum Retroviruses. 2002 Jan 1;18(1):49-56. doi: 10.1089/088922202753394718. AIDS Res Hum Retroviruses. 2002. PMID: 11804556
-
Prevention of HIV infection by passive immunization with HIV immunoglobulin.AIDS Res Hum Retroviruses. 1991 Dec;7(12):971-3. doi: 10.1089/aid.1991.7.971. AIDS Res Hum Retroviruses. 1991. PMID: 1812946
-
Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.Proc Natl Acad Sci U S A. 1988 Sep;85(18):6944-8. doi: 10.1073/pnas.85.18.6944. Proc Natl Acad Sci U S A. 1988. PMID: 3413127 Free PMC article.
-
Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).J Infect Dis. 2000 Feb;181(2):548-54. doi: 10.1086/315224. J Infect Dis. 2000. PMID: 10669338 Clinical Trial.
Cited by
-
Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12.J Virol. 1997 Oct;71(10):7198-206. doi: 10.1128/JVI.71.10.7198-7206.1997. J Virol. 1997. PMID: 9311792 Free PMC article.
-
Can repeated plasma donation by asymptomatic HIV-infected individuals delay the onset of AIDS?Philos Trans R Soc Lond B Biol Sci. 1997 Jul 29;352(1355):763-70. doi: 10.1098/rstb.1997.0060. Philos Trans R Soc Lond B Biol Sci. 1997. PMID: 9279896 Free PMC article. Clinical Trial.
-
Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140.J Virol. 1998 Dec;72(12):9656-67. doi: 10.1128/JVI.72.12.9656-9667.1998. J Virol. 1998. PMID: 9811699 Free PMC article.
-
High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses.Cytometry A. 2011 Aug;79(8):603-12. doi: 10.1002/cyto.a.21084. Epub 2011 Jul 6. Cytometry A. 2011. PMID: 21735545 Free PMC article.
-
Enhancement of antibody-dependent cellular cytotoxicity of neonatal cells by interleukin-2 (IL-2) and IL-12.Clin Diagn Lab Immunol. 1998 Jan;5(1):98-104. doi: 10.1128/CDLI.5.1.98-104.1998. Clin Diagn Lab Immunol. 1998. PMID: 9455889 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
